Churg Strauss Syndrome Market Research Report – Forecast to 2027

Global Churg Strauss Syndrome Market, by Diagnosis (Blood Test, Imaging, Biopsy), by Treatment (Biologics, Immunoglobulin, Corticosteroid, Immunosuppressive Drug, and Others), End-Users (Hospitals, Clinics, Laboratories, Therapeutics Aspects, and Others)

ID: MRFR/Pharma/4923-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global churg Strauss syndrome market is expected to grow during the forecast period (2018 to 2023) at a CAGR of ~ 4.1 %.


Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign of churg Strauss syndrome. It also affects nose, sinuses, lung, heart, and nerves. There are no medications on this and while it is rare some people got this disease because of asthma medication called Montelukast. As due to change in environmental conditions lots of people are suffering from allergic and immune disorders. Hence this leads to an increase in the growth of this market.


Factors such as growing occurrences of churg Strauss syndrome and other allergic reactions and asthma, rising geriatric population, and growing incidences of churg Strauss syndrome in children are expected to drive the growth of the market during the assessment period.


On the other hand, the unfavorable reimbursement scenario in many developing countries and lack of awareness regarding autoimmune disorder in people can hinder the growth of the market during the forecast period.


Segmentation


The global churg Strauss syndrome market is segmented on basis of diagnosis, treatment, end users. Based on diagnosis the churg Strauss syndrome market is further segmented into blood test, imaging, biopsy, chest x-ray, CT scan. On basis of treatment, the syndrome is further segmented into biologics, immunoglobulin, corticosteroid, immunosuppressive drugs and others. Immunoglobulin is further sub-segmented into vaccines, steroids, and others. Based on end users the churg Strauss syndrome is further segmented into hospitals, clinics, laboratory, therapeutics aspects, and others.


Key players


Some of the key players in the global churg Strauss syndrome market are Slivergate, Heron Therapeutics, Inc., IRX Therapeutics, Inc., Brabourne Enterprises Ltd, Rupus Research Alliance, Tianjin Tianyao Pharmaceuticals Co., Ltd, and Grifols, S.A.


Regional Market Summary


Global Churg Strauss Syndrome Market Share, by Region, 2018 (%)


Churg Strauss Syndrome Market Share


Source: MRFR Analysis


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The churg Strauss syndrome market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European churg Strauss syndrome market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The churg Strauss syndrome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The churg Strauss syndrome market in the Middle East and Africa has been segmented into the Middle East and Africa.


Geographically, the Americas is anticipated to dominate the global churg Strauss syndrome market. The market growth in this region is attributed to the increasing asthma patients, change in environmental conditions, increasing allergic reaction and others. Moreover, the increasing incidence of asthma in the aging population is expected to fuel the growth of the market in this region. 


Europe is expected to be the second largest market in the globe owing to the increasing number of hay fever, increasing government expenditure for sinus pain and inflammation, increasing number of people visiting a doctor for allergic reaction problem.


Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of immunosuppressant disease and hyper-eosinophilia related problems in developing countries and increasing incidences of granulomatosis.  


The Middle East and Africa is expected to account for the lowest market share in the global churg Strauss syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.


Global Churg Strauss Syndrome Market, by Diagnosis



  • Blood test

  • Imaging

  • Biopsy

  • Chest X-ray

  • CT Sca


Global Churg Strauss Syndrome Market, by treatment



  • Biologics

  • Immunoglobulin

  • Vaccines

  • Steroid

  • Other

  • Corticosteroid

  • Immunosuppressive drugs

  • Others


Global Churg Strauss Syndrome Market, by End-User



  • Laboratories

  • Hospitals

  • Clinics

  • Therapeutic usage


Global Churg Strauss Syndrome Market, by Region


Americas


  • North America

  • US

  • Canada

  • South America


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa


  • Middle East

  • Africa


Intended Audience



  • Hospitals and clinics

  • Laboratories and associations

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting



Frequently Asked Questions (FAQ) :


Churg strauss syndrome market would achieve 4.1% CAGR during the forecast period.

Lack of reimbursement strategy and awareness can deter the churg strauss market growth.

Churg strauss market includes segments like blood test, imaging, biopsy, chest x-ray, and CT scan.

The treatment type includes immunoglobulin, biologics, immunosuppressive drugs, corticosteroid, and others.

The end users are hospitals, laboratory, clinics, therapeutic aspects, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Churg Strauss Syndrome Market, by Diagnosis

6.1 Introduction

6.2 Blood Test

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Imaging

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Chest X-Ray

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 CT Scan

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Churg Strauss Syndrome Market, by Treatment

7.1 Introduction

7.2 Biologics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Immunoglobulin

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.1 Vaccines

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2 Steroid

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Corticosteroid

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Immunosuppressive drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027


Chapter 8. Global Churg Strauss Syndrome Market, End-User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Laboratory

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Therapeutics aspects

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6 Others.

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Churg Strauss Syndrome Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Slivergate

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Heron Therapeutic, Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financials Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 IRX Therapeutic Inc

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financials Overview

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.4 Brabourne Enterprises Ltd

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financials Overview

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.5 Rupus Research Alliance

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financials Overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Tianjin Tianyao Pharmaceuticals Co., Ltd

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financials Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Grifols, S.A.

11.7.1 Company Overview

11.7.2 Product Overview

11.7.3 Financials Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

Chapter 13. Appendix


LIST OF TABLES

Table 1 Global Churg Strauss Syndrome Market Synopsis, 2020–2027

Table 2 Global Churg Strauss Syndrome Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Churg Strauss Syndrome Market, by Region, 2020–2027 (USD Million)

Table 4 Global Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 5 Global Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 6 Global Churg Strauss Syndrome Market, by End-User, 2020–2027 (USD Million)

Table 7 North America: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 8 North America: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 9 North America: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 10 US: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 11 US: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 12 US: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 13 Canada: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 14 Canada: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 15 Canada: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 16 South America: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 17 South America: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 18 South America: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 19 Europe: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 20 Europe: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 21 Europe: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 22 Western Europe: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 23 Western Europe: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 24 Western Europe: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 25 Eastern Europe: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 26 Eastern Europe: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 27 Eastern Europe: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 31 Asia-Pacific: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Churg Strauss Syndrome Market, by Diagnosis, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Churg Strauss Syndrome Market, by Treatment, 2020–2027 (USD Million)

Table 34 Middle East & Africa: Churg Strauss Syndrome Market, by End-Users, 2020–2027 (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Churg Strauss Syndrome Market

Figure 3 Segmentation Market Dynamics for Global Churg Strauss Syndrome Market

Figure 4 Global Churg Strauss Syndrome Market Share, By Diagnosis, 2020

Figure 5 Global Churg Strauss Syndrome Market Share, By Treatment, 2020

Figure 6 Global Churg Strauss Syndrome Market Share, By End-Users, 2020

Figure 7 Global Churg Strauss Syndrome Market Share, By Region, 2020

Figure 8 North America: Global Churg Strauss Syndrome Market Share, By Country, 2020

Figure 9 Europe: Global Churg Strauss Syndrome Market Share, By Country, 2020

Figure 10 Asia-Pacific: Global Churg Strauss Syndrome Market Share, By Country, 2020

Figure 11 Middle East & Africa: Global Churg Strauss Syndrome Market Share, By Country, 2020

Figure 12 Global Churg Strauss Syndrome Market: Company Share Analysis, 2020 (%)

Figure 13 Slivergate: Key Financials

Figure 14 Slivergate: Segmental Revenue

Figure 15 Slivergate: Geographical Revenue

Figure 16 Heron Therapeutic, Inc: Key Financials

Figure 17 Heron Therapeutic, Inc: Segmental Revenue

Figure 18 Heron Therapeutic, Inc: Geographical Revenue

Figure 19 IRX Therapeutic, Inc: Key Financials

Figure 20 IRX Therapeutic, Inc: Segmental Revenue

Figure 21 IRX Therapeutic, Inc: Geographical Revenue

Figure 22 Brabourne Enterprises Ltd: Key Financials

Figure 23 Brabourne Enterprises Ltd: Segmental Revenue

Figure 24 Brabourne Enterprises Ltd: Geographical Revenue

Figure 25 Rupus Research Alliance: Key Financials

Figure 26 Rupus Research Alliance: Segmental Revenue

Figure 27 Rupus Research Alliance: Geographical Revenue

Figure 28 Tianjin Tianyao Pharmaceuticals Co., Ltd: Key Financials

Figure 29 Tianjin Tianyao Pharmaceuticals Co., Ltd: Segmental Revenue

Figure 30 Tianjin Tianyao Pharmaceuticals Co., Ltd: Geographical Revenue

Figure 31 Grifols, S.A: Key Financials

Figure 32 Grifols, S.A: Segmental Revenue

Figure 33 Grifols, S.A: Geographical Revenue